amodiaquine has been researched along with Electrocardiogram QT Prolonged in 3 studies
Amodiaquine: A 4-aminoquinoline compound with anti-inflammatory properties.
amodiaquine : A quinoline having a chloro group at the 7-position and an aryl amino group at the 4-position.
| Excerpt | Relevance | Reference |
|---|---|---|
| " These side effects include various mild heart rate changes (amodiaquine) to excessive prolongation of the QT interval (halofantrine) which may lead to lethal arrhythmias such as Torsade de Pointes (TdP)." | 4.82 | Antimalarial drugs: QT prolongation and cardiac arrhythmias. ( Dumotier, B; Traebert, M, 2005) |
| "Amodiaquine is a 4-aminoquinoline antimalarial similar to chloroquine that is used extensively for the treatment and prevention of malaria." | 2.72 | The cardiovascular effects of amodiaquine and structurally related antimalarials: An individual patient data meta-analysis. ( Ashley, EA; Chan, XHS; Djimdé, A; Fanello, CI; Haeusler, IL; Hanafiah, M; Hanboonkunupakarn, B; Kiechel, JR; Lacerda, MV; Lee, SJ; Ogutu, B; Onyamboko, MA; Pike, J; Siqueira, AM; Taylor, WR; White, NJ; Win, YN, 2021) |
| "There was no evidence of proarrhythmia with any treatment during the study although dihydroartemisinin-piperaquine, artesunate-amodiaquine and artemether-lumefantrine significantly prolonged QTc." | 1.51 | Evaluation of the effects on the QT-interval of 4 artemisinin-based combination therapies with a correction-free and heart rate-free method. ( Beavogui, AH; Borghini-Fuhrer, I; Djimdé, AA; Duparc, S; Felices, M; Funck-Brentano, C; Khan, Y; Ouedraogo, JB; Ouologuem, N; Sagara, I; Sirima, SB; Soulama, I; Voiriot, P, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, XHS | 1 |
| Haeusler, IL | 1 |
| Win, YN | 1 |
| Pike, J | 1 |
| Hanboonkunupakarn, B | 1 |
| Hanafiah, M | 1 |
| Lee, SJ | 1 |
| Djimdé, A | 1 |
| Fanello, CI | 1 |
| Kiechel, JR | 1 |
| Lacerda, MV | 1 |
| Ogutu, B | 1 |
| Onyamboko, MA | 1 |
| Siqueira, AM | 1 |
| Ashley, EA | 1 |
| Taylor, WR | 1 |
| White, NJ | 1 |
| Funck-Brentano, C | 1 |
| Ouologuem, N | 1 |
| Duparc, S | 1 |
| Felices, M | 1 |
| Sirima, SB | 1 |
| Sagara, I | 1 |
| Soulama, I | 1 |
| Ouedraogo, JB | 1 |
| Beavogui, AH | 1 |
| Borghini-Fuhrer, I | 1 |
| Khan, Y | 1 |
| Djimdé, AA | 1 |
| Voiriot, P | 1 |
| Traebert, M | 1 |
| Dumotier, B | 1 |
2 reviews available for amodiaquine and Electrocardiogram QT Prolonged
| Article | Year |
|---|---|
The cardiovascular effects of amodiaquine and structurally related antimalarials: An individual patient data meta-analysis.
Topics: Adolescent; Adult; Amodiaquine; Antimalarials; Bradycardia; Cardiotoxicity; Child; Child, Preschool; | 2021 |
Antimalarial drugs: QT prolongation and cardiac arrhythmias.
Topics: Amodiaquine; Drug Approval; Electrophysiology; Humans; Long QT Syndrome; Malaria; Phenanthrenes; Ris | 2005 |
1 other study available for amodiaquine and Electrocardiogram QT Prolonged
| Article | Year |
|---|---|
Evaluation of the effects on the QT-interval of 4 artemisinin-based combination therapies with a correction-free and heart rate-free method.
Topics: Adolescent; Amodiaquine; Antimalarials; Arrhythmias, Cardiac; Artemether; Artemether, Lumefantrine D | 2019 |